Ironwood Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of gastrointestinal (GI) diseases. It discovers, develops, and commercializes medications, including LINZESS® (linaclotide), aimed at improving patient care in the GI field. The company leverages insights and expertise to address critical patient needs and collaborates with the GI community to advance treatment options.
